@_Ripense_ @el_pais Zepzelca aún está pendiente de realizar estudios aleatorios. Aún así, sus efectos secundarios son severos. 👇 https://t.co/froMZF7QvW
RT @RamsaAnna: Buenas noticias para la Lurbinectedina por cortesía de Javier Ayen .https://t.co/7AHrOMHYni @Kostarof @pharma_jonpi @PhrmMar
RT @RamsaAnna: Buenas noticias para la Lurbinectedina por cortesía de Javier Ayen .https://t.co/7AHrOMHYni @Kostarof @pharma_jonpi @PhrmMar
Buenas noticias para la Lurbinectedina por cortesía de Javier Ayen .https://t.co/7AHrOMHYni @Kostarof @pharma_jonpi @PhrmMar
Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin. - PubMed - NCBI https://t.co/hSsaZUMMRq
New article: Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin. https://t.co/K6zK97kx6F #lungcancer #oncology
RT @pharma_jonpi: Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin . Published 2 Mar…
Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin . Published 2 March 2020 Volume 2020:11 Pages 27—31 #pharmamar #lungcancer #LSCL https://t.co/LZkgYBwNda